HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The very low density lipoprotein receptor-associated pontocerebellar hypoplasia and dysmorphic features in three Turkish patients.

Abstract
Pontocerebellar hypoplasia consists of a rare heterogeneous group of congenital neurodevelopmental disorders characterized by hypoplasia and atrophy of the cerebellar cortex, dentate and pontine nuclei, and inferior olives. The very low density lipoprotein receptor protein is an integral part of the reelin signaling pathway, which guides neuroblast migration in the cerebral cortex and cerebellum. Mutations in this receptor cause nonprogressive cerebellar ataxia, mental retardation, and cerebellar hypoplasia. In this report, we present 3 patients from 2 different families displaying very low density lipoprotein receptor-associated pontocerebellar hypoplasia, cortical dysplasia, mental retardation, and bipedal gait. One of the siblings has also displayed dysmorphic features, as we previously reported before the identification of the genetic defect in this family.
AuthorsFatma Mujgan Sonmez, Joseph G Gleeson, Figen Celep, Sibel Kul
JournalJournal of child neurology (J Child Neurol) Vol. 28 Issue 3 Pg. 379-83 (Mar 2013) ISSN: 1708-8283 [Electronic] United States
PMID22532556 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Receptors, LDL
  • Reelin Protein
  • VLDL receptor
  • RELN protein, human
Topics
  • Adult
  • Atrophy (pathology)
  • Brain (abnormalities, pathology)
  • Child, Preschool
  • Female
  • Humans
  • Intellectual Disability (genetics, pathology)
  • Magnetic Resonance Imaging
  • Male
  • Malformations of Cortical Development (genetics, pathology)
  • Mutation
  • Olivopontocerebellar Atrophies (genetics, pathology)
  • Receptors, LDL (genetics)
  • Reelin Protein
  • Siblings
  • Turkey

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: